Clinical trials show progress in migraine frequency, skin cancer prevention
-
1:20
’The hole in your heart is never going to be replaced’: Family...
-
1:30
MCSO investigating deadly shooting at Center Street Park
-
1:11
MPS superintendent says there is no timeline for closing or merging...
-
0:50
Getting a taste of Summerfest early at the second ’SummerFeast’
-
0:55
14th annual ’Heal the Hood’ block party and resource fair...
-
2:27
Protesters rally outside Ridglan Farms, call for release of remaining...
-
1:53
Looking for a new home in Oak Creek? Some construction students...
-
2:12
Schlesinger’s Saturday Showcase (5/30)...Lots of plant sales,...
-
3:10
Finishing off May on a quiet and cool note before another warmup...
-
2:49
Francesca Hong stands by comments about having “vision“ for...
-
2:42
Beer garden expected to open in Milwaukee’s Red Arrow Park...
-
1:00
Milwaukee named the best city for creatives, report says
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.